期刊文献+

小鼠同基因型移植物抗宿主病发生机制及其意义

Immunological Mechanism of Mouse Syngeneic Graft Versus Host Disease Model and Its Significance
下载PDF
导出
摘要 目的:初步探讨小鼠同基因型移植物抗宿主病(SGVHD)的发生机制,为研究移植物抗白血病效应奠定基础。方法:用同基因骨髓细胞重建致死剂量X线照射的小鼠,用环孢素A(CsA)腹腔注射诱导治疗21d。停药后每日观察小鼠临床症状,在小鼠出现GYHD样症状时,取肝脏、结肠、耳朵、皮肤和胸腺进行组织学检查,并检测肝脏、结肠组织细胞因子和协同刺激分子的表达。结果:67%(19/28)的模型组小鼠产生GVHD样症状,组织病理检查发现GVHD样小鼠结肠和肝脏有组织坏死和大量炎细胞浸润,而移植对照组均未出现GVHD样症状,组织学未见明显异常。R7-PCR检测发现GVHD样小鼠结肠和肝脏组织中共刺激分子CD137mRNA水平和细胞因子IL-12、IFN-Υ和TNF-α mRNA水平较移植对照组小鼠的水平升高。结论:CsA可诱导同基因型骨髓移植小鼠产生GVHD样症状,Th1类细胞因子参与了SGVHD的发生,为进一步研究$GVHD的抗肿瘤机制建立了技术平台。 Objective: To primarily explore the immunological mechanism of SGVHD and provide a platform for study of graft-versus leukemia. Methods: Lethally irradiated C3H/HeJ mice were reconstructed with syngeneic bone marrow cells and induced with cyclosporine (CsA) for 21d. After cessation of CsA , the clinical symptoms of SGVHD(such as weight loss, diarrhea, hunching, runting) were observed. The histological changes of murine liver, colon, skin, thymus and ear were examined by routine pathological methods. Meanwhile, the expression of cytokines in mice colon and liver were examined by RT-PCR. Results: 67% ( 19/28 ) of mice developed GVHD - like clinical symptom in SGVHD-induced group and their pathological detection of liver and colon showed tissue necrosis and increased lymphocyte infiltration . The levels of costimulatory molecule ( CD137 ) and Th1-type cytokines( IL-12, IFN-γ, and TNF-α) mRNA were enhanced in liver and colon of SGVHD mice, compared with control mice. Conclusion: The CsA can induce syngeneic BMT recipients of C3H/HeJ mice to develop SGVHD, and costimulatory molecules and Thl type cytokines played an important role in development of SGVHD.
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 2005年第4期244-248,共5页 Chinese Journal of Cancer Biotherapy
基金 国家自然科学基金(30271247)
关键词 同基因型移植物抗宿主病 细胞因子 抗肿瘤 SGVHD cytokine anti-tumor
  • 相关文献

参考文献12

  • 1Glazier A, Tutschka PJ , Farmer ER, et al. Graft-versus host disease in cyclosporine a treated rats after syngeneic and autologous bone marrow reconstitution[ J ]. J Exp Med, 1983, 158 (1) : 1-8.
  • 2Bryson JS, Jennings CD, Caywood BE, et al. Induction of a syngeoeic graft-versus-host disease-like syndrome in DBA/2 mice[ J ].Transplantation, 1989, 48 (6) : 1042-1047.
  • 3Giralts S , Weber D , Colome M, et aL Phase I trial of cyclosporine-induced autologous graft-versus-host disease in patients with multiple myeloma undergoing high dose chemotherapy with autologous stem cell rescue [ J ]. J Clin Oncol, 1997, 15 (2) : 667-673.
  • 4Bryson JS, Jennings CD, Lowery DM, et al. Rejection of an MHC class Ⅱ negative tumor following induction of routine syngeneic graft-versus-host disease[ J ]. Bone Marrow Transplant, 1999, 23(4) : 363-372.
  • 5Hess AD, Thoburn C J, Miura Y, et al. Antigen-specific T-lymphocyte responses in acute and chronic syngeneic graft-versus-host disease[J]. Transplant Proc, 2005, 37(1 ): 53-56.
  • 6Flanagan DL, Jennings CD, Bryson JS. Th1 cytokines and NK cells participate in the development of routine syngeneic graft-versus-host disease[J]. J Immunol, 1999, 163(3): 1170-1177.
  • 7Flanagan DM, Jennings CD, Goes SW, et al. Nitric oxide participates in the intestinal pathology associated with routine syngeneic graft-versus-host disease[ J ]. J Leukoe Biol, 2002, 72(4) : 762-768.
  • 8张利宁,JS.Bryson.结肠上皮内CD4^+CD8^-/CD4^-CD8^-αβT淋巴细胞及细胞因子在sGVHD发生发展中的改变[J].中华微生物学和免疫学杂志,2002,22(5):537-540. 被引量:3
  • 9Bryson JS, Zhang L, Goes SW, et al. CD4^+ Τ cells mediate mufine syngeneic graft-versus-host disease-associated colitis [ J ]. J Immunol, 2004, 172( 1 ) : 679-687.
  • 10Cheney RT, Sprent J . Capacity of cyclospofine to induce autograft-versus-host disease and impair intrathymic T cell differentiation[J]. Transplantation Proc , 1985, 17: 528-536.

二级参考文献9

  • 1Glazier A, Tutschka PJ, Farmer ER, et al. Graft-versus host disease in cyclosporine A treated rats after syngeneic and autologous bone marrow transplantation and cyclosporine A: treatment. J Exp Med, 1983, 158: 1-8.
  • 2Giralts S, Weber D, Colome M, et al. Phase Ⅰ trail of cyclosporine-induced autologous graft-versus-host disease in patients with multiple myeloma undergoing high dose chemotherapy with autologous stem cell rescue. J Clin Oncol, 1997, 5 (2): 667-673.
  • 3Bryson JS, Jennings CD, Caywood BE, et al. Induction of a syngeneic graft-versus-host disease-like syndrome in DBA/2 mice. Transplantation, 1989, 48 (17): 1042-1047.
  • 4Cheney RT, Sprent J. Capacity of cyclosporine to induce auto-graft-versus-host disease and impair intrathymic T cell differentiation. Transplantation Proc, 1985, 17: 528-536.
  • 5Bryson JS, Caywood BE, Kaplan AM. et al. Relationship of cyclosporine A-mediated inhibition of clonal deletion and development of syngeneic graft-versus-host disease. J Immunol, 1991, 147: 391-406.
  • 6Flanagan DL, Jennings CD, Bryson JS. Th1 cytokines and NK cells participate in the development of murine syngeneic graft-versus-host disease. J Immunol, 2000, 165: 1171-1177.
  • 7Goodman T, Lefrancois L. Intraepithelial lymphocytes. Anatomical site, not T cell receptor form, dicates phenotype and function. J Exp Med, 1989, 170: 1569-1581.
  • 8Zhang ZX, Yang LM, Young KJ, et al. Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression. Nature Medicine, 2000, 6(7): 782-789.
  • 9Liu MF, Yang CY, Chao SC, et al. Distribution of double-negative(CD4-CD8-, DN)T cell in blood and synovial fluid form patients with rheumatoid arthritis. Clin Rheumatol, 1999, 18 (3): 227-231.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部